
Cecilia Pompili MD PhD FACS
@pompili_cecilia
General Thoracic Surgeon, Associate Professor focusing on patient reported outcomes (PROMs) in lung cancer care @HullYorkMed @ests_womenThor
ID: 1174353444402008070
18-09-2019 16:04:23
1,1K Tweet
1,1K Followers
2,2K Following

This is what happens when you walk into the #ASCO25 Patient Advocacy lounge with a few The White Ribbon Project™ ribbons. Thanks Heidi Nafman-Onda & Jill Feldman for helping me bring a big bunch of mini ribbons back to the UK 🇬🇧 Smaller ribbons; just as powerful. #LCSM



“The future of staging is molecular.” Key message from Anna McGuire MD MSc kicking off #ELIXR25. I emphatically agree. TNM is all anatomic, yet biology is king. TNM approximates both disease biology & duration of disease, but fails to address response to ever-improving therapies.


Fantastic talk by Salma Jabbour on high risk SABR. Highlights that Squamous call lung cancer at higher risk of recurrence post SABR. Also discussed competing causes of mortality, ctDNA and addition of IO 👏🏽👏🏽


#ELIXR25🍁 Thought-provoking talk by Mara Antonoff, MD, FACS on whether staging should be based on biology rather than anatomy- YES! Supporting thoughts: - deferring prognosis evaluation until initial response to Tx - propose local Tx after systemic tx MD Anderson Cancer Center OncoAlert #LCSM


#ELIXR25🍁 Getting ready for the ‘Frenemies’ debate! Neoadj vs Periop ChemoIO in resectable NSCLC 🥊Tina Cascone🇺🇸 MD Anderson Cancer Center Versus 🥊Patrick Forde🇮🇪Trinity St James's Cancer Institute Let the games begin! OncoAlert #LCSM


#ELIXR25🍁 Fun faculty dinner digesting the day, catching up with friends & making new ones x Thanks to our Canadian colleagues for showing us how it’s done 🇨🇦 Jonathan Spicer MD PhD Mara Antonoff, MD, FACS Cecilia Pompili MD PhD FACS Boris Sepesi MD FACS Wenzhao ZHONG Patrick Forde Henning Willers, MD, FASTRO #TinaCascone


☀️Day2 #ELIXR conference - patient-centered discussions in the morning. Cecilia Pompili MD PhD FACS presenting the dire needs and challenges of obtaining comprehensive assessment of QOL/PRO.


Dr Cecilia Pompili MD PhD FACS provides an overview of patient-reported outcomes in perioperative trials at #ELIXR25. Definitions of patient-related factors for attrition from interventions varies among trials, making it challenging to assess collectively. We need standardization. #LCSM



Cecilia Pompili MD PhD FACS Anna McGuire MD MSc Jonathan Spicer MD PhD Boris Sepesi MD FACS Jarushka Naidoo Within IASLC, there are efforts to identify what to measure, when, and how to holistically capture all relevant variables to patient experience within our clinical trials. #ELIXR25 Cecilia Pompili MD PhD FACS


#ELIXR25 Early-Stage #LungCancer Conference in beautiful #Montreal🇨🇦organized by Jonathan Spicer MD PhD McGill University & Team was multiD, interactive, high quality science, with patient input = Great Success👏🙏 #radonc needs to participate in early-stage #lungcancer management/conferences:


Please share - the 10th Lung Cancer Europe survey is looking at the very critical topic of mental health & lung cancer. It's available in 19 languages & closes on July 6th. If you reside in Europe, please spare 15 minutes to take part in this important work 👉 lungcancereurope.eu/2025/05/28/10t…

We are delighted to launch our MWF “Manifesto for Women Doctors”. Valuing women doctors would improve UK health. Individual and system actions are needed. medicalwomensfederation.org.uk/our-work/mwf-m… Prof Scarlett McNally. With thanks for quotes/facts/concepts from 20 other organisations/individuals.


Experts like these are the driving force of the NHS, UK research and a lifeline for patients. With the strength of Roy Castle Lung Cancer Foundation behind it, we keep moving forward—bringing hope, care, and change #LCSM #35AnniversaryRCLF Sanjay Popat LungSpecialist Tom Newsom-Davis BTOG



